glp 1 inhibitor drugs GLP-1 Drugs: For Multiple Chronic Conditions Comparison of GLP-1 receptor agonists

Maintain energy levels and support metabolic processes, contributing to an active and balanced lifestyle

(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.

Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials

Curious about GLP-1 medications like Ozempic and Wegovy

Here, we aimed to provide an overview of retatrutide's safety and effectiveness in treating obesity.